Cargando…
Cutaneous leukocytoclastic vasculitis associated with verapamil and atorvastatin: A case report
We report a case of biopsy‐proven cutaneous leukocytoclastic vasculitis developing 10 days after starting verapamil and atorvastatin in a patient with long‐standing Sjogren's syndrome. This highlights the need to monitor for this rare adverse effect.
Autores principales: | Aw, Yi Tong Vincent, McGuane, Jonathan Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352572/ https://www.ncbi.nlm.nih.gov/pubmed/37469372 http://dx.doi.org/10.1002/ccr3.7683 |
Ejemplares similares
-
Gastroenterology Cases of Cutaneous Leukocytoclastic Vasculitis
por: Karatoprak, Cumali, et al.
Publicado: (2013) -
Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
por: Blyth, Dana M., et al.
Publicado: (2012) -
Cutaneous leukocytoclastic vasculitis in the presence of
methimazole therapy
por: Ribeiro, Carla de Oliveira, et al.
Publicado: (2013) -
Cutaneous Leukocytoclastic Vasculitis Associated with Erlotinib
por: Sawada, Takahiro, et al.
Publicado: (2016) -
Sibutramine (Reductil®)-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report
por: Ha, You Jin, et al.
Publicado: (2011)